Full-Year FY26 Consensus Forecast: Analysts expect full-year FY26 revenue in the range of A$380M – A$390M, representing a year-over-year revenue growth of roughly 3% to 5% compared to FY25
Valuation & Comparative Context
Trailing P/E (TTM):~48.5x – 50.7x (based on recent reported 12-month net profit).
Why the Forward P/E expand relative to Trailing: Net profit after tax (NPAT) is temporarily compressed in the near term due to significant growth capital expenditures—specifically heavy ongoing investments into data centre capacity (e.g., IC3 SuperWest) and increased depreciation/financing costs.
EV/EBITDA Multiple: Shares trade at a forward EV/EBITDA of approximately 17.5x – 18.0x, reflecting strong underlying EBITDA cash flow performance relative to net bottom-line profit.
Update 11/8: Reported record 2Q26 revenue of US$21.7m (+18% YoY, +13% QoQ), driven by US RECELL unit volume growth and contributions from Cohealyx and PermeaDerm. Management upgraded FY26 revenue guidance to US$86-89m and anticipates cash-flow breakeven in 4Q26.
Intel Corporation – Common plans a US$15bn common stock offering, likely its first public share sale since listing in 1971, citing a strong and sustainable demand environment for AI compute.